NEW YORK (GenomeWeb News) – Laboratory Corporation of America today reported that its fourth-quarter revenues increased 3 percent, beating analyst expectations, as disruptions due to inclement weather hit the firm's bottom line.

The Burlington, NC-based clinical lab firm brought in total revenues of $1.41 billion for the three months ended Dec. 31, exceeding Wall Street's consensus expectation of $1.39 billion and above Q4 2011 revenues of $1.37 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.